Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Janus

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
JAMA Internal Medicine|July 9, 2019
Effectiveness of a Bundled Intervention Including Adjunctive Corticosteroids on Outcomes of Hospitalized Patients With Community-Acquired Pneumonia: A Stepped-Wedge Randomized Clinical TrialMelanie Lloyd, Amalia Karahalios, Edward Janus, et al.
BMC Public Health|September 21, 2012
Implementation salvage experiences from the Melbourne diabetes prevention studyJames Dunbar, Andrea Hernan, Edward Janus, et al.
Asia-Pacific Journal of Public Health|January 7, 2009
Chronic disease risk factors in rural Australia: results from the Greater Green Triangle risk factor surveysTiina Laatikainen, Edward Janus, Annamari Kilkkinen, et al.
BMJ Open|August 27, 2013
A comparison of Australian rural and metropolitan cardiovascular risk and mortality: the Greater Green Triangle and North West Adelaide population surveysPhilip Tideman, Anne W Taylor, Edward Janus, et al.
Journal of the American Heart Association|February 18, 2022
Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID StudyMalcolm West, Adrienne Kirby, Ralph A Stewart, et al.
International Journal of Epidemiology|January 4, 2021
Cohort Profile: The Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) and the follow-up studiesDavid Tak Wai Lui, Chi Ho Lee, Yu Cho Woo, et al.
Journal of the American Heart Association|October 25, 2024
Plasma Protein Biomarkers and Long-Term Cardiovascular Mortality Risk in Patients With Chronic Coronary Heart DiseaseRalph A H Stewart, Kristy P Robledo, Andrew M Tonkin, et al.
Journal of the American Heart Association|June 29, 2022
B-Type Natriuretic Peptide and Long-Term Cardiovascular Mortality in Patients With Coronary Heart DiseaseRalph A H Stewart, Adrienne Kirby, Harvey D White, et al.
Plos One|August 9, 2018
Results of the first recorded evaluation of a national gestational diabetes mellitus register: Challenges in screening, registration, and follow-up for diabetes riskDouglas I R Boyle, Vincent L Versace, James A Dunbar, et al.
Health Informatics Journal|April 15, 2021
Towards optimising chronic kidney disease detection and management in primary care: Underlying theory and protocol for technology development using an Integrated Knowledge Translation approachJo-Anne Manski-Nankervis, Karyn Alexander, Ruby Biezen, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
JAMA Internal Medicine|July 9, 2019
Effectiveness of a Bundled Intervention Including Adjunctive Corticosteroids on Outcomes of Hospitalized Patients With Community-Acquired Pneumonia: A Stepped-Wedge Randomized Clinical TrialMelanie Lloyd, Amalia Karahalios, Edward Janus, et al.
BMC Public Health|September 21, 2012
Implementation salvage experiences from the Melbourne diabetes prevention studyJames Dunbar, Andrea Hernan, Edward Janus, et al.
Asia-Pacific Journal of Public Health|January 7, 2009
Chronic disease risk factors in rural Australia: results from the Greater Green Triangle risk factor surveysTiina Laatikainen, Edward Janus, Annamari Kilkkinen, et al.
BMJ Open|August 27, 2013
A comparison of Australian rural and metropolitan cardiovascular risk and mortality: the Greater Green Triangle and North West Adelaide population surveysPhilip Tideman, Anne W Taylor, Edward Janus, et al.
Journal of the American Heart Association|February 18, 2022
Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID StudyMalcolm West, Adrienne Kirby, Ralph A Stewart, et al.
International Journal of Epidemiology|January 4, 2021
Cohort Profile: The Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) and the follow-up studiesDavid Tak Wai Lui, Chi Ho Lee, Yu Cho Woo, et al.
Journal of the American Heart Association|October 25, 2024
Plasma Protein Biomarkers and Long-Term Cardiovascular Mortality Risk in Patients With Chronic Coronary Heart DiseaseRalph A H Stewart, Kristy P Robledo, Andrew M Tonkin, et al.
Journal of the American Heart Association|June 29, 2022
B-Type Natriuretic Peptide and Long-Term Cardiovascular Mortality in Patients With Coronary Heart DiseaseRalph A H Stewart, Adrienne Kirby, Harvey D White, et al.
Plos One|August 9, 2018
Results of the first recorded evaluation of a national gestational diabetes mellitus register: Challenges in screening, registration, and follow-up for diabetes riskDouglas I R Boyle, Vincent L Versace, James A Dunbar, et al.
Health Informatics Journal|April 15, 2021
Towards optimising chronic kidney disease detection and management in primary care: Underlying theory and protocol for technology development using an Integrated Knowledge Translation approachJo-Anne Manski-Nankervis, Karyn Alexander, Ruby Biezen, et al.
Pageof 4